Critical role of c-Kit in beta cell function: increased insulin secretion and protection against diabetes in a mouse

Z C Feng1, J Li, B A Turco

  • 1Victoria Research Laboratories, Room A5-140, 800 Commissioners Road East, London, ON, Canada, N6C 2V5.

Diabetologia
|May 15, 2012
PubMed
Abstract

Insights

Stem cell factor receptor c-Kit plays a protective role in pancreatic beta cells. Overexpressing c-Kit improves beta cell function and protects against diabetes, suggesting it as a potential therapeutic target.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Diabetes Research

Background:

  • The receptor tyrosine kinase c-Kit and its ligand, stem cell factor, are crucial for pancreatic beta cell survival and differentiation.
  • Mutations in c-Kit lead to loss of kinase activity and the development of diabetes, as observed in c-Kit(Wv) mice.

Purpose of the Study:

  • To investigate the intrinsic role of c-Kit in beta cells and elucidate the underlying mechanisms influencing beta cell function.
  • To assess the potential of c-Kit as a therapeutic target for diabetes.

Main Methods:

  • Generation of a novel transgenic mouse model with specific beta cell c-KIT overexpression (c-KitβTg).
  • Analysis of isolated islets from c-KitβTg mice to explore molecular pathways.
  • Evaluation of c-Kit's ability to protect against high-fat-diet-induced diabetes and rescue c-Kit(Wv) mice from diabetes.

Main Results:

  • c-KitβTg mice showed enhanced beta cell function, improved insulin secretion, and increased beta cell mass and proliferation under high-fat-diet conditions.
  • Upregulation of insulin receptor, IRSs, Akt and GSK3β phosphorylation, and key transcription factors was observed in c-KitβTg islets.
  • Overexpression of c-KIT in beta cells successfully rescued the diabetic phenotype in c-Kit(Wv) mice.

Conclusions:

  • c-Kit plays a direct protective role in pancreatic beta cells by regulating glucose metabolism and overall beta cell function.
  • These findings highlight c-Kit as a potential novel therapeutic target for the treatment of diabetes.

Related Concept Videos

Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...